1. Home
  2. IRD vs HSON Comparison

IRD vs HSON Comparison

Compare IRD & HSON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRD
  • HSON
  • Stock Information
  • Founded
  • IRD 2018
  • HSON 1999
  • Country
  • IRD United States
  • HSON United States
  • Employees
  • IRD N/A
  • HSON N/A
  • Industry
  • IRD
  • HSON Professional Services
  • Sector
  • IRD
  • HSON Consumer Discretionary
  • Exchange
  • IRD NYSE
  • HSON Nasdaq
  • Market Cap
  • IRD 36.1M
  • HSON 40.7M
  • IPO Year
  • IRD N/A
  • HSON N/A
  • Fundamental
  • Price
  • IRD $1.13
  • HSON $12.82
  • Analyst Decision
  • IRD Strong Buy
  • HSON
  • Analyst Count
  • IRD 1
  • HSON 0
  • Target Price
  • IRD $8.00
  • HSON N/A
  • AVG Volume (30 Days)
  • IRD 159.2K
  • HSON 2.5K
  • Earning Date
  • IRD 02-15-2025
  • HSON 03-13-2025
  • Dividend Yield
  • IRD N/A
  • HSON N/A
  • EPS Growth
  • IRD N/A
  • HSON N/A
  • EPS
  • IRD N/A
  • HSON N/A
  • Revenue
  • IRD $8,381,000.00
  • HSON $140,427,000.00
  • Revenue This Year
  • IRD N/A
  • HSON N/A
  • Revenue Next Year
  • IRD $29.37
  • HSON $8.83
  • P/E Ratio
  • IRD N/A
  • HSON N/A
  • Revenue Growth
  • IRD N/A
  • HSON N/A
  • 52 Week Low
  • IRD $0.81
  • HSON $11.73
  • 52 Week High
  • IRD $2.77
  • HSON $19.70
  • Technical
  • Relative Strength Index (RSI)
  • IRD N/A
  • HSON 44.15
  • Support Level
  • IRD N/A
  • HSON $12.61
  • Resistance Level
  • IRD N/A
  • HSON $13.65
  • Average True Range (ATR)
  • IRD 0.00
  • HSON 0.39
  • MACD
  • IRD 0.00
  • HSON 0.06
  • Stochastic Oscillator
  • IRD 0.00
  • HSON 38.97

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

About HSON Hudson Global Inc.

Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management, and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.

Share on Social Networks: